January 8, 2021
Rochelle Park, NJ – The DAK Group, a leading investment bank specializing in middle market mergers and acquisitions worldwide, announces the sale of a majority stake of its client, Astrix Software Technology, Inc. (d.b.a. Astrix Technology Group) headquartered in Red Bank, NJ to Quad-C Management, Inc. of Charlottesville, VA. The DAK Group served as the exclusive [...]
January 8, 2021
MENLO PARK, Calif. -- Pacific Biosciences of California, Inc. (NASDAQ: PACB), a leading provider of high-quality sequencing solutions, today announced the appointments of Mark Van Oene as Chief Operating Officer and Peter Fromen as Chief Commercial Officer, both effective as of January 8, 2021. “I am delighted to have Mark Van Oene and Peter Fromen [...]
January 8, 2021
MENLO PARK, Calif . -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality, long-read sequencing platforms, today announced that the Wellcome Sanger Institute has committed to purchase seven new Sequel IIe Systems and upgrade its five existing Sequel II Systems to increase its long-read sequencing capabilities for projects including the Darwin Tree [...]
QIAGEN announces appointment of new Supervisory Board member
January 8, 2021
Dr. Toralf Haag appointed to Supervisory Board and a member of the Audit Committee Venlo, the Netherlands – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that Dr. Toralf Haag has been appointed a member of the Supervisory Board with immediate effect. He will also become a member of the Audit Committee. Dr. Haag was [...]
Emulate Announces Organ-on-a-Chip Application and Services Roadmap
January 8, 2021
Expanded In Vitro Modeling Tools Will Enable Researchers to Better Understand the Effects of Advanced Biologics and Gene Therapies BOSTON, Mass. - Emulate, Inc., a leading provider of advanced in vitro models, today announced an application roadmap for their market leading organ-on-a-chip technology that expands beyond small molecule applications and addresses the growing focus on [...]
SARS-CoV-2 Antigen Protein Kits
January 8, 2021
AMSBIO has introduced a series of kit products based upon high-quality SARS-CoV-2 antigen proteins to improve the efficiency of anti-SARS-CoV-2 drugs and vaccines development.These new kit products include SARS-CoV-2 inhibitor screening kits, antibody titer serologic assay kits, antigen detection kit and antigen pre-coated plates.SARS-CoV-2 is an enveloped positive-stranded RNA virus that consists of four structural [...]
Merck Announces Formation of Merck Digital Ethics Advisory Panel
January 8, 2021
Designed to provide guidance around evolving digital business models, the panel will address digital ethics questions for all three business sectors of Merck. DARMSTADT, GERMANY Panel designed to provide ethical counsel to inform all business processes, supporting the evolving data-driven, digital landscape Merck, a leading science and technology company, today announced the creation of its [...]
January 7, 2021
BILLERICA, Mass. -- Bruker Corporation (Nasdaq: BRKR) today announced that three world-leading institutions are now accelerating their research into functional structural biology and human disease with new Bruker ultra-high field nuclear magnetic resonance (NMR) spectrometers installed in 2020. Novel GHz-class NMR technology enables advanced research to obtain structural, functional and binding information of intrinsically disordered proteins [...]
PerkinElmer to Acquire Oxford Immunotec Global PLC
January 7, 2021
PerkinElmer to acquire Oxford Immunotec for USD 22.00 per share in cash Transaction expected to be completed in the first half of 2021 WALTHAM, Mass. & LONDON -- PerkinElmer, Inc. (NYSE: PKI) (“PerkinElmer”) and Oxford Immunotec Global PLC (NASDAQ: OXFD) ("Oxford Immunotec" or the “Company”) are pleased to announce they have reached an agreement on terms under which PerkinElmer will acquire Oxford [...]
January 7, 2021
SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced it will supply the U.S. Centers for Disease Control and Prevention (CDC) with a customized version of Twist SARS-CoV-2 Synthetic RNA Controls for use in the [...]
